**Core Concept**
The question is about managing raised intraocular pressure (IOT) associated with uveitis, focusing on the appropriate use of **corticosteroids** and **anti-glaucoma medications**. Uveitis is inflammation of the uvea, which can lead to increased IOT.

**Why the Correct Answer is Right**
Since the correct answer isn't specified, let's discuss the general approach: in uveitis with raised IOT, **corticosteroids** are used to reduce inflammation, and certain **anti-glaucoma medications** like **prostaglandin analogs** can be used cautiously. However, **steroids** can sometimes worsen glaucoma by increasing IOT.

**Why Each Wrong Option is Incorrect**
**Option A:** Without the specific options, it's challenging to provide detailed incorrectness for each. Generally, options that include **prostaglandin analogs** or **beta-blockers** might be considered for use in glaucoma associated with uveitis, as they can help reduce IOT.
**Option B:** Similarly, this would depend on the specific medication or class listed.
**Option C:** And this option as well.
**Option D:** Typically, **corticosteroids** themselves are not incorrect for use in uveitis but must be managed carefully regarding IOT.

**Clinical Pearl / High-Yield Fact**
A key point in managing uveitis with raised IOT is balancing the reduction of inflammation with the control of intraocular pressure, as **uncontrolled IOT** can lead to vision loss.

**Correct Answer:** Correct Answer: D. Steroids.